Dr. Matthew Miller, MD
Claim this profileDoernbecher Children's Hospital Oregon Health & Science University
Studies Cerebral Gliomas
Studies Brain Tumor
6 reported clinical trials
14 drugs studied
Area of expertise
1Cerebral Gliomas
H3.3K27M positive
Stage I
Stage II
2Brain Tumor
H3.3K27M positive
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Matthew Miller, MD is currently running
Combination Therapy
for Brain Cancer
This trial is testing a combination of three drugs to treat a specific type of brain tumor called diffuse midline gliomas (DMGs). These drugs aim to stop the tumor from growing by blocking enzymes that the cancer cells need. The trial focuses on patients with DMGs because current treatments are not very effective for them.
Recruiting1 award Phase 229 criteria
Trametinib + Everolimus
for Recurrent Brain Cancer
This phase I trial studies the side effects and best dose of trametinib and everolimus in treating pediatric and young adult patients with gliomas that have come back (recurrent). Trametinib acts by targeting a protein in cells called MEK and disrupting tumor growth. Everolimus is a drug that may block another pathway in tumor cells that can help tumors grow. Giving trametinib and everolimus may work better to treat low and high grade gliomas compared to trametinib or everolimus alone.
Recruiting1 award Phase 135 criteria
More about Matthew Miller, MD
Clinical Trial Related3 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Matthew Miller, MD has experience with
- Nivolumab
- MOCTR
- USCTR
- Everolimus
- Trametinib
- K27M Peptide
Breakdown of trials Matthew Miller, MD has run
Cerebral Gliomas
Brain Tumor
Relapse
Brain Cancer
Diffuse Intrinsic Pontine Glioma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matthew Miller, MD specialize in?
Matthew Miller, MD focuses on Cerebral Gliomas and Brain Tumor. In particular, much of their work with Cerebral Gliomas has involved H3.3K27M positive patients, or patients who are Stage I.
Is Matthew Miller, MD currently recruiting for clinical trials?
Yes, Matthew Miller, MD is currently recruiting for 4 clinical trials in Portland Oregon. If you're interested in participating, you should apply.
Are there any treatments that Matthew Miller, MD has studied deeply?
Yes, Matthew Miller, MD has studied treatments such as Nivolumab, mOCTR, USCTR.
What is the best way to schedule an appointment with Matthew Miller, MD?
Apply for one of the trials that Matthew Miller, MD is conducting.
What is the office address of Matthew Miller, MD?
The office of Matthew Miller, MD is located at: Doernbecher Children's Hospital Oregon Health & Science University, Portland, Oregon 97239 United States. This is the address for their practice at the Doernbecher Children's Hospital Oregon Health & Science University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.